Published in Int J Radiat Oncol Biol Phys on March 01, 2010
Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol (2012) 2.23
Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys (2011) 1.76
MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med (2012) 1.40
Stereotactic body radiation therapy in the re-irradiation situation--a review. Radiat Oncol (2013) 1.08
Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy. Pharmacogenomics (2011) 1.07
Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov (2014) 1.03
Visualization of a variety of possible dosimetric outcomes in radiation therapy using dose-volume histogram bands. Pract Radiat Oncol (2011) 1.03
Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy. Mol Cancer Res (2012) 1.02
STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics. Radiother Oncol (2013) 0.97
Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. Int J Radiat Oncol Biol Phys (2011) 0.95
Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med (2011) 0.95
A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapy. Int J Radiat Oncol Biol Phys (2010) 0.92
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization. Int J Mol Sci (2016) 0.91
Clinical development of new drug-radiotherapy combinations. Nat Rev Clin Oncol (2016) 0.91
Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. EBioMedicine (2016) 0.90
The clinical case for proton beam therapy. Radiat Oncol (2012) 0.90
Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment. Radiat Oncol (2012) 0.87
(Radio)biological optimization of external-beam radiotherapy. Comput Math Methods Med (2012) 0.87
Investigating end-to-end accuracy of image guided radiation treatment delivery using a micro-irradiator. Phys Med Biol (2013) 0.86
Analytical model for out-of-field dose in photon craniospinal irradiation. Phys Med Biol (2013) 0.85
Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction. Radiat Oncol (2013) 0.85
Random variation in rectal position during radiotherapy for prostate cancer is two to three times greater than that predicted from prostate motion. Br J Radiol (2014) 0.84
The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. Semin Radiat Oncol (2015) 0.83
Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study. Br J Cancer (2011) 0.83
Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy. Br J Cancer (2013) 0.82
Radiobiological model-based bio-anatomical quality assurance in intensity-modulated radiation therapy for prostate cancer. J Radiat Res (2012) 0.81
Enhancing the efficacy of radiation therapy: premises, promises, and practicality. J Clin Oncol (2014) 0.81
New approach for treatment of vertebral metastases using intensity-modulated radiotherapy. Strahlenther Onkol (2011) 0.80
Feasibility and radiation induced toxicity regarding the first application of transperineal implementation of biocompatible balloon for high dose radiotherapy in patients with prostate carcinoma. Radiat Oncol (2013) 0.80
Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus: a case report with a diagnostic and therapeutic discussion. Int J Clin Oncol (2011) 0.80
A quality index for equivalent uniform dose. J Med Phys (2011) 0.80
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys (2016) 0.80
A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol (2016) 0.80
Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma. BMC Cancer (2014) 0.79
Role of external beam radiation therapy in management of hepatocellular carcinoma. J Clin Exp Hepatol (2014) 0.79
Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer. Radiat Oncol (2013) 0.79
Dosimetry for radiopharmaceutical therapy. Semin Nucl Med (2014) 0.79
Three-dimensional conformal radiotherapy for hepatocellular carcinoma in patients unfit for resection, ablation, or chemotherapy: a retrospective study. ScientificWorldJournal (2013) 0.78
Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer. World J Clin Cases (2014) 0.78
In vivo dosimetry of thyroid doses from different irradiated sites in children and adolescents: a cross-sectional study. Radiat Oncol (2014) 0.78
Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation. Br J Radiol (2015) 0.78
A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation Schedules Versus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer. Breast Care (Basel) (2016) 0.78
Advancing our quantitative understanding of radiotherapy normal tissue morbidity. Acta Oncol (2014) 0.77
Treatment planning evaluation and optimization should be biologically and not dose/volume based. Med Phys (2015) 0.77
Transformation of physical DVHs to radiobiologically equivalent ones in hypofractionated radiotherapy analyzing dosimetric and clinical parameters: a practical approach for routine clinical practice in radiation oncology. Comput Math Methods Med (2013) 0.77
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. Br J Cancer (2016) 0.77
Strategic evaluation of interventions to prevent consequential late proctitis after prostate radiation therapy: new clinical trial designs should be considered. Cancer Biol Ther (2014) 0.77
The current progress and future prospects of personalized radiogenomic cancer study. Biomedicine (Taipei) (2015) 0.77
Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation. Br J Radiol (2015) 0.77
Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy. Radiat Oncol (2015) 0.77
Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy? J Radiat Res (2015) 0.76
Nonsurgical treatment for localized hepatocellular carcinoma. Curr Oncol Rep (2014) 0.76
Can we obtain planning goals for conformal techniques in neoadjuvant and adjuvant radiochemotherapy for gastric cancer patients? Rep Pract Oncol Radiother (2016) 0.75
Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis. Oncotarget (2017) 0.75
Modeling Radiotherapy Induced Normal Tissue Complications: An Overview beyond Phenomenological Models. Comput Math Methods Med (2016) 0.75
Model assessment of individual tumor control rate and adverse effects in comparing locally advanced cervical cancer treatment using intracavitary with and without interstitial brachytherapy. J Contemp Brachytherapy (2016) 0.75
Personalized treatment planning with a model of radiation therapy outcomes for use in multiobjective optimization of IMRT plans for prostate cancer. Radiat Oncol (2016) 0.75
Comparison of hybrid volumetric modulated arc therapy (VMAT) technique and double arc VMAT technique in the treatment of prostate cancer. Radiol Oncol (2015) 0.75
Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy. Br J Radiol (2016) 0.75
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy. Br J Radiol (2016) 0.75
Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns. Oncol Lett (2014) 0.75
Correlation of conventional and conformal plan parameters for predicting radiation pneumonitis in patients treated with breast cancer. J Breast Cancer (2012) 0.75
Helical TomoTherapy for locally advanced or recurrent breast cancer. Radiat Oncol (2017) 0.75
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin. Am J Clin Oncol (2016) 0.75
A Kindler syndrome-associated squamous cell carcinoma treated with radiotherapy. Rep Pract Oncol Radiother (2016) 0.75
A quantitative comparison of the performance of three deformable registration algorithms in radiotherapy. Z Med Phys (2013) 0.75
Data-driven Markov models and their application in the evaluation of adverse events in radiotherapy. J Radiat Res (2013) 0.75
A dose-volume histogram based decision-support system for dosimetric comparison of radiotherapy treatment plans. Radiat Oncol (2015) 0.75
Variation in uterus position prior to brachytherapy of the cervix: A case report. J Med Life (2017) 0.75
The radiosurgery fractionation quandary: single fraction or hypofractionation? Neuro Oncol (2017) 0.75
Radiogenomics and radiotherapy response modeling. Phys Med Biol (2017) 0.75
Strategies to tackle the challenges of external beam radiotherapy for liver tumors. World J Hepatol (2017) 0.75
A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials. Sci Rep (2017) 0.75
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era. Front Oncol (2017) 0.75
Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys (1991) 13.16
Complication probability as assessed from dose-volume histograms. Radiat Res Suppl (1985) 3.85
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer (2006) 3.65
Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys (1991) 3.64
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys (2006) 3.40
Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol (1992) 2.43
A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys (2007) 1.90
Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys (1991) 1.89
Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys (2006) 1.85
Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2006) 1.71
Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. Int J Radiat Oncol Biol Phys (1995) 1.70
Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys (1988) 1.51
Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys (2006) 1.50
Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol (2007) 1.49
Availability of large-scale evidence on specific harms from systematic reviews of randomized trials. Am J Med (2004) 1.47
Normal tissue effects: reporting and analysis. Semin Radiat Oncol (2003) 1.44
The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol (2003) 1.37
Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat (2008) 1.21
Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.20
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys (2002) 1.20
Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys (2006) 1.20
Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys (2007) 1.17
Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. Int J Radiat Oncol Biol Phys (2005) 1.11
The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys (2007) 1.09
Secondary radiation damage as the main cause for unexpected volume effects: a histopathologic study of the parotid gland. Int J Radiat Oncol Biol Phys (2005) 1.09
Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study. Int J Radiat Oncol Biol Phys (2008) 1.08
Models in radiotherapy: volume effects. Med Phys (1983) 0.99
Increasing toxicity in nonoperative head and neck cancer treatment: investigations and interventions. Int J Radiat Oncol Biol Phys (2007) 0.97
Investigation of the support vector machine algorithm to predict lung radiation-induced pneumonitis. Med Phys (2007) 0.97
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol (2007) 0.96
Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol (1993) 0.93
Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate. Radiother Oncol (2004) 0.89
Data on dose-volume effects in the rat spinal cord do not support existing NTCP models. Int J Radiat Oncol Biol Phys (2005) 0.87
NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy. Phys Med Biol (2007) 0.85
Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys (1997) 0.85
The effect of irradiated volume on the chronic radiation damage of the rat large bowel. Strahlenther Onkol (1995) 0.83
Volume effects in radiobiology as applied to radiotherapy. Radiother Oncol (2000) 0.81
Modelling the dose-volume response of the spinal cord, based on the idea of damage to contiguous functional subunits. Int J Radiat Biol (2001) 0.80
3-D conformal radiation therapy in upper gastrointestinal cancer. The University of Michigan experience. Front Radiat Ther Oncol (1996) 0.80
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA (2009) 9.47
Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol (2004) 4.63
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma. N Engl J Med (2013) 4.49
Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys (2010) 4.33
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys (2009) 3.91
Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys (2010) 3.83
Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys (2010) 3.73
Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys (2002) 3.64
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) 3.61
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys (2006) 3.40
High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys (2005) 3.32
Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. J Clin Oncol (2007) 3.08
Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys (2010) 2.94
How long have I had my cancer, doctor? Estimating tumor age via Collins' law. Oncology (Williston Park) (2011) 2.84
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys (2012) 2.80
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2002) 2.76
Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys (2010) 2.69
Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys (2010) 2.66
Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol (2007) 2.56
Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys (2003) 2.41
Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment. Int J Radiat Oncol Biol Phys (2008) 2.39
Radiation-associated liver injury. Int J Radiat Oncol Biol Phys (2010) 2.39
Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data. Biophys J (2008) 2.27
Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys (2009) 2.27
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol (2012) 2.24
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer (2003) 2.24
Telomeric expression sites are highly conserved in Trypanosoma brucei. PLoS One (2008) 2.22
Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? Int J Radiat Oncol Biol Phys (2008) 2.20
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol (2005) 2.20
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
A microRNA expression signature for cervical cancer prognosis. Cancer Res (2010) 2.14
Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys (2010) 2.14
Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer (2009) 2.08
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol (2008) 2.08
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys (2005) 2.02
Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol (2003) 1.97
Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys (2009) 1.97
Equatorially dominated magnetic field change at the surface of Earth's core. Science (2003) 1.94
The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol (2008) 1.93
A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys (2007) 1.90
Partial volume tolerance of the liver to radiation. Semin Radiat Oncol (2005) 1.85
Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys (2006) 1.85
Progress toward a microradiation therapy small animal conformal irradiator. Med Phys (2006) 1.84
GeneDB--an annotation database for pathogens. Nucleic Acids Res (2011) 1.82
Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys (2010) 1.78
Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy. Cancer J (2006) 1.76
Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg (2009) 1.76
Measurement of lung tumor motion using respiration-correlated CT. Int J Radiat Oncol Biol Phys (2004) 1.74
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood (2009) 1.74
Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys (2010) 1.74
Assessment of the residual error in soft tissue setup in patients undergoing partial breast irradiation: results of a prospective study using cone-beam computed tomography. Int J Radiat Oncol Biol Phys (2007) 1.73
Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys (2010) 1.72
Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res (2009) 1.69
Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys (2006) 1.67
Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. J Clin Oncol (2012) 1.67
Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.65
The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys (2010) 1.65
Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys (2004) 1.64
Second malignant neoplasms and cardiovascular disease following radiotherapy. J Natl Cancer Inst (2012) 1.64
Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys (2005) 1.64
Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys (2009) 1.64
FGF9 suppresses meiosis and promotes male germ cell fate in mice. Dev Cell (2010) 1.64
Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. Int J Radiat Oncol Biol Phys (2007) 1.61
Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer (2005) 1.57
Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.56
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol (2007) 1.55
Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. Int J Radiat Oncol Biol Phys (2005) 1.55
One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate. J Clin Oncol (2008) 1.54
The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys (2006) 1.52
Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys (2005) 1.49
4D-CT motion estimation using deformable image registration and 5D respiratory motion modeling. Med Phys (2008) 1.49
Point: Hyperthermia with radiation for chest wall recurrences. J Natl Compr Canc Netw (2007) 1.49
Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys (2003) 1.49
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer (2012) 1.49
Predicting radiotherapy-induced cardiac perfusion defects. Med Phys (2005) 1.47
Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer (2005) 1.47
Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys (2010) 1.46
Comparing radical prostatectomy and brachytherapy for localized prostate cancer. Oncology (Williston Park) (2004) 1.46
The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys (2012) 1.46
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys (2010) 1.44